Clinical data
Clinical data is an intervention with 9 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate Cancer
Use of N-Butyl Cyanoacrylate in Transarterial Emergency Embolization
MYocardial DOmmages Related to COVID-19
A Multi-domain Approach for the Characterization and Early Diagnosis of Neurodevelopmental Disorders
EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19
Clinical Trials (9)
Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate Cancer
Use of N-Butyl Cyanoacrylate in Transarterial Emergency Embolization
MYocardial DOmmages Related to COVID-19
A Multi-domain Approach for the Characterization and Early Diagnosis of Neurodevelopmental Disorders
EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19
Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19
Radioiodine-avid Bone Metastases From Thyroid Cancer Without Structural Abnormality
Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT
Breast Cancer Registry - National University Health System, Singapore
All 9 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 9